<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Research in Molecular Medicine</title>
<title_fa>Research in Molecular Medicine</title_fa>
<short_title>Res Mol Med (RMM)</short_title>
<subject>Medical Sciences</subject>
<web_url>http://rmm.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1348</journal_id_issn>
<journal_id_issn_online>2322-133X</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/rmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1393</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>3</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Synergistic effect of Achillea millefolium L. combined with bleomycin on prostate cancer cell </title>
	<subject_fa>هماتولوژی و آنکولوژی</subject_fa>
	<subject>Hematology &amp; Oncology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;: The aim of this study was to investigate the effect of methanolic extract of &lt;i&gt;Achillea millefolium &lt;/i&gt;L&lt;i&gt;.&lt;/i&gt; (MEA) on the antiproliferative activity of bleomycin on human prostate cancer and normal skin cells.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Materials and Methods&lt;/strong&gt;: Human prostate cancer cell (DU-145) and human non-malignant fibroblast cell (HFFF2) were treated with MEA at various concentrations ( 20, 100, 500, 1000 and 2000 &amp;micro;g/ml), bleomycin alone and with their combinations. Further their MEA and bleomycin effects on cell viability were evaluated. Free radical scavenging property was determined for this herbal extract.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;: The combination of &lt;i&gt;Achillea millefolium&lt;/i&gt; with bleomycin increased significantly inhibition of cell growth in cancer cell. MEA enhanced significantly cytotoxicity induced by bleomycin with 60% and 49% in survival rate at doses 1000 and 2000 &amp;micro;g/ml, respectively, while it was 85% in bleomycin-treated cells. MEA did not exhibit any cytotoxicity on HFFF2 cells.&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Conclusion&lt;/strong&gt;: Study suggests that &lt;i&gt;Achillea millefolium&lt;/i&gt; enhanced the cell toxicity induced by bleomycin in the prostate cancer cell without any significant toxicity on normal cell.&lt;/p&gt;

&lt;p&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Achillea millefolium, prostate cancer, Antiproliferative, MTT, antioxidantbleomycin</keyword>
	<start_page>12</start_page>
	<end_page>17</end_page>
	<web_url>http://rmm.mazums.ac.ir/browse.php?a_code=A-10-25-6&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Somayeh</first_name>
	<middle_name></middle_name>
	<last_name>Shahani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>so.shahani@yahoo.com</email>
	<code>10031947532846005877</code>
	<orcid>10031947532846005877</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacognosy and Biotechnology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Negar</first_name>
	<middle_name></middle_name>
	<last_name>Hamzekanlu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mn4564@yahoo.com</email>
	<code>10031947532846005878</code>
	<orcid>10031947532846005878</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Faculty of Pharmacy, International Unit, Mazandaran University of Medical Sciences, Ramsar, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Neda</first_name>
	<middle_name></middle_name>
	<last_name>Zakeri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mn4564@yahoo.com</email>
	<code>10031947532846005879</code>
	<orcid>10031947532846005879</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Faculty of Pharmacy, International Unit, Mazandaran University of Medical Sciences, Ramsar, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Jalal</first_name>
	<middle_name></middle_name>
	<last_name>Hosseinimehr</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sjhosseinim@yahoo.com</email>
	<code>10031947532846005880</code>
	<orcid>10031947532846005880</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Radiopharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
